Eric Low

Eric has worked in medical research, health technology appraisal, market access, health policy and patient organisations for over 30 years. He established Myeloma UK in 1996, developing it from an idea to a successful and respected organisation he led as Chief Executive until 2017. During this time, he designed and implemented a disease blueprint and bench-to-bedside strategic model to accelerate and prioritise the discovery, development of and access to effective new treatments, best practices, as well as information and support for patients and their families In 2017, Eric established a small specialist consultancy specialising primarily in strategic HTA and market access, life sciences and healthcare policy, and patient and patient group engagement. Eric is committed and focused on improving patient outcomes. He has a strong track record of delivery and success in building multi-stakeholder research collaborations, patient coalitions, market access strategies, changing policy, and d